These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29447376)

  • 1. The relationship between depression and biologic treatment response in rheumatoid arthritis: An analysis of the British Society for Rheumatology Biologics Register.
    Matcham F; Davies R; Hotopf M; Hyrich KL; Norton S; Steer S; Galloway J
    Rheumatology (Oxford); 2018 May; 57(5):835-843. PubMed ID: 29447376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent serious infections in patients with rheumatoid arthritis-results from the British Society for Rheumatology Biologics Register.
    Subesinghe S; Rutherford AI; Byng-Maddick R; Leanne Hyrich K; Benjamin Galloway J
    Rheumatology (Oxford); 2018 Apr; 57(4):651-655. PubMed ID: 29340619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunistic infections in rheumatoid arthritis patients exposed to biologic therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Rutherford AI; Patarata E; Subesinghe S; Hyrich KL; Galloway JB
    Rheumatology (Oxford); 2018 Jun; 57(6):997-1001. PubMed ID: 29529307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective Evaluation of the Effects of Prevalent Depressive Symptoms on Disease Activity in Rheumatoid Arthritis Patients Treated With Biologic Response Modifiers.
    Rathbun AM; Harrold LR; Reed GW
    Clin Ther; 2016 Jul; 38(7):1759-1772.e3. PubMed ID: 27368116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining Pathways to Improvements in Fatigue in Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Druce KL; Jones GT; Macfarlane GJ; Basu N
    Arthritis Rheumatol; 2015 Sep; 67(9):2303-10. PubMed ID: 26108189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordant inflammation and pain in early and established rheumatoid arthritis: Latent Class Analysis of Early Rheumatoid Arthritis Network and British Society for Rheumatology Biologics Register data.
    McWilliams DF; Ferguson E; Young A; Kiely PD; Walsh DA
    Arthritis Res Ther; 2016 Dec; 18(1):295. PubMed ID: 27964757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients receiving anti-TNF therapies experience clinically important improvements in RA-related fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Druce KL; Jones GT; Macfarlane GJ; Basu N
    Rheumatology (Oxford); 2015 Jun; 54(6):964-71. PubMed ID: 25313148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining Changes in Central and Peripheral Pain as Mediates of Fatigue Improvement: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Druce KL; Jones GT; Macfarlane GJ; Basu N
    Arthritis Care Res (Hoboken); 2016 Jul; 68(7):922-6. PubMed ID: 26605992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial.
    Matcham F; Norton S; Scott DL; Steer S; Hotopf M
    Rheumatology (Oxford); 2016 Feb; 55(2):268-78. PubMed ID: 26350486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Etanercept Therapy on Disease Activity and Health-Related Quality of Life in Moderate Rheumatoid Arthritis Patients Population from a National British Observational Cohort.
    Kotak S; Mardekian J; Horowicz-Mehler N; Shah A; Burgess A; Kim J; Gemmen E; Boyd H; Koenig A
    Value Health; 2015 Sep; 18(6):817-23. PubMed ID: 26409609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal effect of depressive symptoms on the longitudinal evolution of rheumatoid arthritis disease activity.
    Rathbun AM; Harrold LR; Reed GW
    Arthritis Care Res (Hoboken); 2015 May; 67(6):765-75. PubMed ID: 25384985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. British Society for Rheumatology Biologics Register.
    Silman A; Symmons D; Scott DG; Griffiths I
    Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii28-9. PubMed ID: 14532144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study.
    Matcham F; Ali S; Irving K; Hotopf M; Chalder T
    BMC Musculoskelet Disord; 2016 Apr; 17():155. PubMed ID: 27068100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of behavioural and psychological factors on medication adherence over time in rheumatoid arthritis patients: a study in the biologics era.
    Morgan C; McBeth J; Cordingley L; Watson K; Hyrich KL; Symmons DP; Bruce IN
    Rheumatology (Oxford); 2015 Oct; 54(10):1780-91. PubMed ID: 25972390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Most patients who reach disease remission following anti-TNF therapy continue to report fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Druce KL; Bhattacharya Y; Jones GT; Macfarlane GJ; Basu N
    Rheumatology (Oxford); 2016 Oct; 55(10):1786-90. PubMed ID: 27330158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of biologics initiation in moderate versus severe rheumatoid arthritis: evidence from a United States registry.
    Kavanaugh A; Keystone E; Greenberg JD; Reed GW; Griffith JM; Friedman AW; Saunders KC; Ganguli A
    Rheumatology (Oxford); 2017 Jul; 56(7):1095-1101. PubMed ID: 28340006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of patients with rheumatoid arthritis in Qatar: a cross-sectional study.
    Lutf A; Poil AR; Hammoudeh M
    Int J Rheum Dis; 2014 Jan; 17(1):63-5. PubMed ID: 24472269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predicting pain and early discontinuation of tumour necrosis factor-α-inhibitors in people with rheumatoid arthritis: results from the British society for rheumatology biologics register.
    McWilliams DF; Walsh DA
    BMC Musculoskelet Disord; 2016 Aug; 17():337. PubMed ID: 27515300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is swollen to tender joint count ratio a new and useful clinical marker for biologic drug response in rheumatoid arthritis? Results from a Swedish cohort.
    Kristensen LE; Bliddal H; Christensen R; Karlsson JA; Gülfe A; Saxne T; Geborek P
    Arthritis Care Res (Hoboken); 2014 Feb; 66(2):173-9. PubMed ID: 23982986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.